Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#Claudin18.2 ×

Regulatory Updates

Aug 30, 2026•1 min read

Claudin18.2‑Targeted CAR‑T Therapy Achieves First Global Approval for Solid Tumor

Claudin18.2‑targeted CAR‑T therapy is the first CAR‑T to receive global approval for a solid tumor.